Atrial fibrillation (AF) and atrial flutter, as significant causes of global hospitalizations, impose substantial clinical and economic burdens. Often precipitating symptomatic episodes of tachyarrhythmia, these conditions account for a considerable portion—between 50% and 67%—of AF-related healthcare expenditures. Beyond the immediate financial implications, AF and flutter are associated with serious health risks, including increased mortality and … Leggi tutto Atrial Fibrillation and Flutter: A Decade of Insights from Australia and New Zealand